Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Mills

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
The American Journal of Surgical Pathology|November 8, 2017
HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL)Anne M Mills, Joseph D Coppock, Brian C Willis, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 7, 2026
HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic TractEyas Alzayadneh, Megan E Dibbern, Joseph Rabban, et al.
Human Pathology|August 4, 2018
Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomasJoseph D Coppock, Ashley K Volaric, Anne M Mills, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1Erik A Dill, Patrick M Dillon, Timothy N Bullock, et al.
Gynecologic Oncology|January 10, 2017
Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumorsChelsea E Gottlieb, Anne M Mills, Janet V Cross, et al.
Gynecologic Oncology|November 1, 2018
Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomesMackenzie W Sullivan, Fabian T Camacho, Anne M Mills, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 16, 2020
PD-L1 and Mismatch Repair Status in Uterine CarcinosarcomasTaylor M Jenkins, Leigh A Cantrell, Mark H Stoler, et al.
The American Journal of Surgical Pathology|February 7, 2022
HER2 Overexpression and Amplification in Uterine Carcinosarcomas With Serous MorphologyTaylor M Jenkins, Leigh A Cantrell, Mark H Stoler, et al.
The American Journal of Surgical Pathology|September 30, 2016
CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine TrialsAnne M Mills, Cherie Paquette, Tatjana Terzic, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
GATA3 Expression in Common Gynecologic Carcinomas: A Potential PitfallTatjana Terzic, Anne M Mills, Sarah Zadeh, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
The American Journal of Surgical Pathology|November 8, 2017
HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL)Anne M Mills, Joseph D Coppock, Brian C Willis, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 7, 2026
HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic TractEyas Alzayadneh, Megan E Dibbern, Joseph Rabban, et al.
Human Pathology|August 4, 2018
Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomasJoseph D Coppock, Ashley K Volaric, Anne M Mills, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1Erik A Dill, Patrick M Dillon, Timothy N Bullock, et al.
Gynecologic Oncology|January 10, 2017
Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumorsChelsea E Gottlieb, Anne M Mills, Janet V Cross, et al.
Gynecologic Oncology|November 1, 2018
Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomesMackenzie W Sullivan, Fabian T Camacho, Anne M Mills, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 16, 2020
PD-L1 and Mismatch Repair Status in Uterine CarcinosarcomasTaylor M Jenkins, Leigh A Cantrell, Mark H Stoler, et al.
The American Journal of Surgical Pathology|February 7, 2022
HER2 Overexpression and Amplification in Uterine Carcinosarcomas With Serous MorphologyTaylor M Jenkins, Leigh A Cantrell, Mark H Stoler, et al.
The American Journal of Surgical Pathology|September 30, 2016
CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine TrialsAnne M Mills, Cherie Paquette, Tatjana Terzic, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
GATA3 Expression in Common Gynecologic Carcinomas: A Potential PitfallTatjana Terzic, Anne M Mills, Sarah Zadeh, et al.
Pageof 11